View clinical trials related to Osteosarcoma in Children.
Filter by:A phase 2 study of regorafenib in combination with nivolumab in patients with refractory or recurrent osteosarcoma.
The purpose of this study is to evaluate the safety and efficacy of nivolumab, or nivolumab in combination with azacitidine in participants with recurrent, resectable osteosarcoma